Elekta stock holds steady ahead of new quarterly results
Published on 08/26/2026 at 20:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Elekta (ISIN SE0000163628) stock is trading in the mid-50s SEK as of August 25, 2026, with recent market data showing a closing price of 56.05 SEK and a modest gain of 2.47% since the start of the year, while investors look ahead to new quarterly figures expected on August 27, 2026.
Market performance into the earnings date
Recent trading on Nasdaq Stockholm shows Elekta B shares closing at 56.05 SEK on August 25, 2026, representing a 0.81% rise on the day and a 2.47% gain since the beginning of 2026. A separate real-time quote snapshot later on August 26, 2026, shows Elekta trading around 55.05 SEK, with a 5-day performance of minus 1.17% and year-to-date performance at plus 2.11%, highlighting that the stock has given back part of its recent gains but remains slightly positive for the year.
This recent price range places Elekta stock just below the 56.05 SEK close from the prior session, indicating that the shares are trading within a narrow band ahead of the upcoming earnings release. For investors, the contrast between the 5-day decline of 1.17% and the positive year-to-date gains underlines how short-term volatility differs from the longer performance trend.
Consensus points to SEK 318 million adjusted operating profit
According to an earnings preview published on August 26, 2026, Elekta is scheduled to present its financial results for the quarter that ended on July 31, 2026, on August 27, 2026. The preview notes that the company is expected to report adjusted operating profit of 318 million SEK for this latest quarter, based on estimates collected from analysts. The same preview highlights that in the comparable quarter a year earlier Elekta reported adjusted operating profit of 235 million SEK, implying a year-over-year increase of 83 million SEK in this key profitability metric.
The analyst consensus also calls for quarterly revenue of 3.63 billion SEK for the period ended July 31, 2026, compared with 3.65 billion SEK in the prior-year quarter, a small decline of 0.31%. This signals that the expected profit improvement is driven more by margin and cost dynamics than by top-line growth. For the current fiscal year, the same survey points to an expected earnings per share of 3.90 SEK, compared with a loss per share of 1.36 SEK in the previous year, and forecasts full-year revenue of 17.32 billion SEK versus 16.72 billion SEK a year earlier, indicating an anticipated revenue increase of 0.60 billion SEK.
Another preview based on consensus data states that Elekta is expected to deliver adjusted operating profit of 318 million SEK, reinforcing the picture that analysts broadly align around this level. The report also references an average price target for the stock of 59.82 SEK, moderately above the latest closing price of 56.05 SEK, suggesting that at least some analysts see limited upside if the company meets expectations.
Analysts see earnings recovery and modest growth
The expectations for a swing from a prior-year earnings per share of minus 1.36 SEK to a projected 3.90 SEK for the current fiscal year underscore that analysts anticipate a significant recovery in profitability. In revenue terms, the forecast increase from 16.72 billion SEK to 17.32 billion SEK for the full year represents growth of 3.6%, indicating that Elekta is expected to expand sales at a measured pace while driving stronger operating leverage and earnings recovery.
At the quarterly level, the anticipated adjusted operating profit of 318 million SEK compared with 235 million SEK a year earlier indicates an increase of about 35%, even though quarterly revenue is projected to slip slightly from 3.65 billion SEK to 3.63 billion SEK. This combination highlights the focus on margins and operational efficiency, which can be especially important in capital equipment and software businesses where order timing and mix affect headline revenue levels from one quarter to another.
Market coverage of Elekta leading into the results emphasizes that the company will present figures for the quarter ending July 31, 2026, on August 27, 2026, and that the outcome relative to these consensus expectations for adjusted operating profit and revenue will be a key driver for the stock. With an average price target around 59.82 SEK compared with the 56.05 SEK latest close, the implied upside is moderate, and any significant deviation from the projected 318 million SEK adjusted operating profit could prompt reassessment of that view.
Elekta radiotherapy solutions as a core driver
Elekta generates its revenue primarily from oncology-related solutions, including linear accelerators, radiotherapy planning software, and related services and maintenance contracts that support cancer treatment centers worldwide. The company also provides stereotactic radiosurgery systems and other precision radiation tools designed to target tumors while sparing surrounding healthy tissue, and these technologies contribute to equipment sales and recurring service revenue.
Beyond hardware, Elekta offers software platforms that help clinicians plan and manage radiation treatments, which can deepen long-term customer relationships and create recurring revenue streams. As hospitals and radiotherapy centers expand capacity or replace older systems, Elekta aims to capture demand for new installations, upgrades, and digital solutions, which in turn influences order intake and backlog metrics reported in its financial results.
Elekta stock trades in Stockholm with modest year-to-date gains
Elekta stock trades on Nasdaq Stockholm, with the B share as the main listed class, and recent market data points to a closing price of 56.05 SEK on August 25, 2026, and a real-time quote around 55.05 SEK on August 26, 2026. The 5-day percentage change of minus 1.17% contrasts with the year-to-date performance of plus 2.11% to plus 2.47%, indicating that while the stock has experienced short-term volatility, it remains modestly higher than at the beginning of the year as investors await the next financial update.
For market participants, the combination of a stock price slightly above its start-of-year level, an average price target of 59.82 SEK, and a consensus forecast of 318 million SEK in adjusted operating profit for the latest quarter defines the near-term backdrop as of late August 2026. The coming earnings release for the quarter ended July 31, 2026, will clarify whether Elekta can deliver the anticipated profit improvement despite a small projected decline in quarterly revenue and whether the expected full-year earnings recovery toward 3.90 SEK per share remains on track.
Read more
Preview of Elekta quarterly results
Radiotherapy portfolio in cancer care
Elekta's product portfolio centers on radiotherapy technology and related solutions that support cancer care in hospitals and specialized treatment centers. The company provides linear accelerators that deliver precise radiation doses, as well as planning and workflow software that enables clinicians to design treatment plans tailored to each patient's condition. These systems are often installed in comprehensive oncology departments and contribute to both equipment and service revenue streams.
In addition to conventional radiotherapy equipment, Elekta offers stereotactic radiosurgery solutions and other advanced treatment platforms intended for highly targeted interventions. These technologies are designed to help healthcare providers deliver effective treatment while minimizing exposure to healthy tissue, which can improve patient outcomes and reduce side effects. As health systems invest in upgrading or expanding their radiotherapy capacity, Elekta's installed base, service contracts, and software offerings play a central role in driving recurring revenue and future growth.
Stock level and investor perspective
As of the latest completed trading session on August 25, 2026, Elekta B shares closed at 56.05 SEK on Nasdaq Stockholm, with a modest increase of 0.81% on the day and a positive year-to-date performance of 2.47%. Subsequent real-time data on August 26, 2026, showed the stock trading near 55.05 SEK, a 5-day change of minus 1.17% but still reflecting year-to-date gains of 2.11%, underscoring that the shares remain slightly ahead of their level at the beginning of 2026 as the market awaits the firm's latest quarterly update.
Fact box
Company: Elekta AB (publ)
ISIN: SE0000163628
Ticker: EKTA B
Exchange: Nasdaq Stockholm
Price (as of August 25, 2026, 6:00 p.m. local time): 56.05 SEK
Market cap: not specified in available data
Sector / Industry: Health care / Medical equipment
Index membership: not specified in available data
